View source for 18251227. SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19 simplified abstract (THE REGENTS OF THE UNIVERSITY OF CALIFORNIA)

=SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19=


==Organization Name==

[[:Category:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA|THE REGENTS OF THE UNIVERSITY OF CALIFORNIA]]


[[Category:THE REGENTS OF THE UNIVERSITY OF CALIFORNIA]]

==Inventor(s)==

[[:Category:Deependra Kumar Ban of San Diego CA (US)|Deependra Kumar Ban of San Diego CA (US)]][[Category:Deependra Kumar Ban of San Diego CA (US)]]

[[:Category:Ratneshwar Lal of La Jolla CA (US)|Ratneshwar Lal of La Jolla CA (US)]][[Category:Ratneshwar Lal of La Jolla CA (US)]]

==SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19 - A simplified explanation of the abstract==


This abstract first appeared for US patent application 18251227 titled 'SIRNA-NANOBOWL-MEDIATED INTERVENTION OF COVID-19

==Simplified Explanation==

'''Abstract:'''
The patent application describes methods, systems, and devices related to siRNA-based nanobowl-mediated intervention for COV-ID-19.

* siRNA-based nanobowl-mediated intervention for COV-ID-19 is the focus of the patent application.
* The methods, systems, and devices described in the patent application aim to provide a novel approach for combating COV-ID-19.
* The intervention involves the use of small interfering RNA (siRNA) delivered through nanobowls.
* The siRNA is designed to target specific genes or viral components of COV-ID-19.
* The nanobowls act as carriers to deliver the siRNA to the target cells.
* The patent application provides details on the design and synthesis of the siRNA and nanobowls.
* The methods, systems, and devices described in the patent application have potential applications in the treatment and prevention of COV-ID-19.

'''Potential Applications:'''
* Treatment of COV-ID-19: The siRNA-based nanobowl-mediated intervention can be used as a therapeutic approach to treat individuals infected with COV-ID-19.
* Prevention of COV-ID-19: The intervention can also be utilized as a preventive measure to reduce the risk of COV-ID-19 infection.
* Research and Development: The methods, systems, and devices described in the patent application can be used in research and development efforts related to COV-ID-19.

'''Problems Solved:'''
* Lack of effective treatments: The siRNA-based nanobowl-mediated intervention provides a potential solution to the lack of effective treatments for COV-ID-19.
* Limited preventive measures: The intervention offers a new approach to prevent COV-ID-19 infection, addressing the limited preventive measures available.

'''Benefits:'''
* Targeted intervention: The siRNA-based approach allows for targeted intervention by specifically targeting genes or viral components of COV-ID-19.
* Enhanced delivery: The use of nanobowls as carriers improves the delivery of siRNA to the target cells, increasing the effectiveness of the intervention.
* Potential versatility: The methods, systems, and devices described in the patent application can be adapted for use with other viral infections, potentially providing a versatile solution.


==Original Abstract Submitted==

Provided are methods, systems, and devices that pertain to siRNA-based nanobowl-mediated intervention for COV-ID-19.



[[Category:A61K41/00]]
[[Category:A61K47/69]]
[[Category:C12N15/113]]
[[Category:A61K45/06]]
[[Category:A61K31/573]]
[[Category:A61K39/215]]
[[Category:A61K47/02]]